|1.||Serisier, David J: 1 article (12/2014)|
|2.||Martin, Megan L: 1 article (12/2014)|
|3.||Bruce, Kenneth D: 1 article (12/2014)|
|4.||Rogers, Geraint B: 1 article (12/2014)|
|5.||Burr, Lucy D: 1 article (12/2014)|
|6.||Iarygin, V N: 1 article (01/2009)|
|7.||Dreval', A A: 1 article (01/2009)|
|8.||Bogomil'skiĭ, M R: 1 article (01/2009)|
|9.||Rakhmanova, I V: 1 article (01/2009)|
|10.||D'iakonova, I N: 1 article (01/2009)|
05/01/1990 - "The results of the trial indicate that 2% mupirocin ointment is as safe and effective as oral erythromycin ethylsuccinate in the treatment of patients with impetigo."
12/01/1988 - "The safety and efficacy of a new topical antiinfective agent, mupirocin, was compared with that of oral erythromycin ethylsuccinate in the treatment of impetigo in children. "
08/01/1989 - "In this study, a new topical antibiotic ointment, mupirocin, was compared with oral erythromycin ethylsuccinate in the treatment of impetigo. "
05/01/1990 - "Sixty patients participated in a bacteriologically controlled, randomized, parallel group comparison of 2% mupirocin ointment (Bactroban) and oral erythromycin ethylsuccinate for the treatment of impetigo. "
11/01/1988 - "Results from this study demonstrate that mupirocin is as effective as systemic erythromycin ethylsuccinate for treatment of pyoderma and impetigo."
|2.||Respiratory Tract Infections (Respiratory Tract Infection)
09/01/1989 - "Erythromycin ethylsuccinate, base and acistrate in the treatment of upper respiratory tract infection: two comparative studies of tolerability."
01/01/1979 - "With its good absorption, its lack of toxicity and its reputation for good diffusion into bronchial secretions, we consider that erythromycin ethylsuccinate should have a major place in the treatment of respiratory tract infections."
03/01/1993 - "In the present double-blind, placebo-controlled trial, the effect of erythromycin ethylsuccinate (0.5 g twice a day for 5 days) on the elimination of nasopharyngeal pathogens and reduction of clinical signs of upper respiratory tract infection, as well as on subjective complaints, was evaluated in 106 adults with acute laryngitis. "
10/01/1990 - "This study indicates that both erythromycin ethylsuccinate and ciprofloxacin are well tolerated and are equally effective for routine empirical treatment of acute respiratory tract infections."
10/01/1990 - "Comparison of oral erythromycin ethylsuccinate and ciprofloxacin in the treatment of acute respiratory tract infections."
10/01/1986 - "In the first phase, erythromycin ethylsuccinate was used as prophylaxis for otitis media in 45 patients in a dose of 10 mg/kg twice daily. "
05/01/1994 - "These included withholding antimicrobials for treatment of the preceding episode of otitis media; use of suboptimal agents for therapy of otitis media (penicillin and, possibly, erythromycin ethylsuccinate); and insufficient duration of treatment."
12/01/1978 - "Ninety young children with otitis media, proven by tympanocentesis culture to be due to Hemophilus influenzae, were treated in a prospective double-blind study with one of three antimicrobial regimens: ampicillin, erythromycin ethylsuccinate, or erythromycin ethylsuccinate with concomitant trisulfapyrimidines. "
01/01/1983 - "The erythromycin ethylsuccinate and acetyl sulfisoxazole combination was effective in treatment of acute otitis media secondary to ampicillin-resistant Haemophilus influenzae. "
05/01/1988 - "Erythromycin ethylsuccinate-sulfamethoxazole mixture vs. amoxicillin for acute otitis media."
|4.||Pharyngitis (Sore Throat)
10/01/1988 - "Roxithromycin and erythromycin ethylsuccinate were equally effective in resolving the symptoms and signs of pharyngitis. "
11/01/1982 - "Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate."
10/01/1988 - "We compared the efficacy and toxicity of roxithromycin and erythromycin ethylsuccinate in the treatment of streptococcal pharyngitis in adults. "
10/01/1988 - "Comparative efficacy and toxicity of roxithromycin and erythromycin ethylsuccinate in the treatment of streptococcal pharyngitis in adults."
01/01/1988 - "Two hundred sixty-five adult and adolescent patients with possible streptococcal pharyngitis were treated with either erythromycin ethylsuccinate or an enteric-coated erythromycin in a twice-daily dosage schedule. "
07/01/1979 - "It was concluded that an excessive protein content in the diet increased the efficacy of monomycin therapy in dysentery children. "
07/01/1979 - "It is recommended that the diet with an excessive protein content be used in monomycin treatment of dysentery children."
07/01/1979 - "[Course of dysentery and the specific alteration of the neutrophils in children in the use of monomycin and a diet with an increased protein content]."
07/01/1978 - "Wide use of eleuterococcus in combination with monomycin for the treatment of children with dysentery is recommended."
07/01/1978 - "An acute dysentery process was studied in 100 children at the age of 1 to 14 years treated with monomycin; 54 patients (the 1st group) were treated with monomycin in combination with eleuterococcus and 46 patients (the 2nd group) were treated with monomycin alone. "
|2.||Anti-Bacterial Agents (Antibiotics)
|8.||Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)
|9.||Clavulanic Acid (Potassium Clavulanate)
|3.||Middle Ear Ventilation (Tympanostomy)